Recursion Pharmaceuticals, Inc. RXRX Payments to Acquire Intangible Assets
Payments to Acquire Intangible Assets at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s payments to acquire intangible assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s payments to acquire intangible assets?
- Recursion Pharmaceuticals, Inc. (RXRX) reported payments to acquire intangible assets of $80K in Q1 2026.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s payments to acquire intangible assets?
- Over 2 years (2022 to 2024), Recursion Pharmaceuticals, Inc.'s payments to acquire intangible assets has grown at a 234.2% compound annual growth rate (CAGR), from $300K to $3.35M.